Teva Plunges as U.S. Sales Drop Amid Generic Price Erosion - Bloomberg
Teva Pharmaceuticals considering 345,000 sq. ft. in Parsippany | Parsippany Focus
Teva Wins Three, Loses Six in Patent Battle Over Migraine Drug Ajovy | BioSpace
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
Lured by $40 million tax break, Teva moving U.S. headquarters from Pa. to North Jersey - WHYY
Closure of another criminal case will help Teva's new CEO to focus on return to growt | Ctech
Teva down as it reports lower sales and profit for 2018
Teva Pharmaceutical reports Q1 2018 | AlphaStreet
FDA approves Teva's generic EpiPen after yearslong delay
BCBS Vermont suing Teva Pharmaceuticals over MS drug marketing | Healthcare Finance News
Teva Reports Massive $11.6 Billion Loss, Predicts Weak 2018 - Business - Haaretz.com
Teva recalls US-made drugs following contamination fears - The Boston Globe
Teva selects North Jersey site for its new North American headquarters. - Philadelphia Business Journal
Teva Pharmaceuticals in peer group American glamour stocks | Valuespectrum.com
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
Here's Why Teva Pharma Stock Is Soaring Today
Battered by a Tough Generics Market, Teva Pharma Emphasizes Biologics | BioSpace
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceutical begins first wave of layoffs in Kansas - Kansas City Business Journal
Teva Pharmaceutical Statistics, Facts, Revenue, Subsidiaries
Teva Pharmaceuticals soars after Warren Buffett's Berkshire Hathaway discloses a stake (TEVA) | Markets Insider
Teva, Murphy Formalize North America Headquarters Move with Ceremony in Israel - New Jersey Business Magazine
Teva Says 2018 Profit Will Keep Falling as Generic Drug Slump Persists - Bloomberg
Teva Pharmaceuticals - Wikipedia
Teva beats first-quarter expectations but still has the same old problems - MarketWatch
